SecSonar.com

Cronos Group Inc. (CRON)

Cronos Group Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Cronos Group Inc. (CRON) is a Drug Manufacturers - Specialty & Generic company based in CA with a market capitalization of $1.1B. Revenue grew 64.4% year-over-year and the company generated $151.6K in free cash flow. This page tracks CRON's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CA · 459 employees · IPO Feb 27, 2018

Valuation

Valuation & price

$2.74 · as of May 26, 2026 · -16.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.97

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$3.27$2.63$1.98Jul 25Dec 25Jul 26Jul 7, 25$2.04Jul 9, 25$2.08Jul 11, 25$2.09Jul 15, 25$2.02Jul 17, 25$2.05Jul 21, 25$2.09Jul 23, 25$2.09Jul 25, 25$2.05Jul 29, 25$2.01Jul 31, 25$1.98Aug 4, 25$2.02Aug 6, 25$2.10Aug 11, 25$2.67Aug 13, 25$2.62Aug 15, 25$2.37Aug 19, 25$2.48Aug 21, 25$2.56Aug 25, 25$2.59Aug 27, 25$2.56Aug 29, 25$2.60Sep 3, 25$2.53Sep 5, 25$2.50Sep 9, 25$2.55Sep 11, 25$2.58Sep 16, 25$2.59Sep 18, 25$2.67Sep 22, 25$2.59Sep 24, 25$2.71Sep 26, 25$2.63Sep 30, 25$2.78Oct 2, 25$2.59Oct 6, 25$2.55Oct 8, 25$2.68Oct 10, 25$2.51Oct 14, 25$2.53Oct 16, 25$2.48Oct 21, 25$2.50Oct 23, 25$2.48Oct 27, 25$2.47Oct 29, 25$2.46Oct 31, 25$2.51Nov 4, 25$2.45Nov 6, 25$2.47Nov 10, 25$2.56Nov 12, 25$2.54Nov 14, 25$2.45Nov 18, 25$2.44Nov 20, 25$2.30Nov 25, 25$2.46Nov 28, 25$2.47Dec 2, 25$2.46Dec 4, 25$2.49Dec 8, 25$2.47Dec 10, 25$2.79Dec 12, 25$3.27Dec 16, 25$3.16Dec 18, 25$2.97Dec 22, 25$2.78Dec 24, 25$2.74Dec 29, 25$2.66Jan 2, 26$2.70Jan 6, 26$2.69Jan 8, 26$2.65Jan 12, 26$2.68Jan 14, 26$2.63Jan 16, 26$2.53Jan 21, 26$2.61Jan 23, 26$2.78Jan 27, 26$2.71Jan 29, 26$2.59Feb 2, 26$2.51Feb 4, 26$2.58Feb 9, 26$2.62Feb 11, 26$2.61Feb 13, 26$2.60Feb 18, 26$2.67Feb 20, 26$2.70Feb 24, 26$2.74Feb 26, 26$2.67Mar 2, 26$2.63Mar 4, 26$2.62Mar 6, 26$2.57Mar 10, 26$2.52Mar 12, 26$2.49Mar 17, 26$2.59Mar 19, 26$2.46Mar 23, 26$2.52Mar 25, 26$2.62Mar 27, 26$2.50Mar 31, 26$2.51Apr 2, 26$2.53Apr 7, 26$2.52Apr 9, 26$2.55Apr 13, 26$2.57Apr 15, 26$2.72Apr 17, 26$2.69Apr 22, 26$2.80Apr 24, 26$2.68Apr 28, 26$2.65Apr 30, 26$2.67May 4, 26$2.65May 6, 26$2.62May 8, 26$2.54May 12, 26$2.77May 14, 26$2.74May 18, 26$2.62May 20, 26$2.67May 22, 26$2.74May 28, 26$2.84Jun 1, 26$2.82Jun 3, 26$2.71Jun 5, 26$2.74Jun 9, 26$2.79Jun 11, 26$2.75Jun 15, 26$2.63Jun 17, 26$2.67Jun 22, 26$2.65Jun 24, 26$2.71Jun 26, 26$2.81Jul 2, 26$2.86
$1.9552-week range$3.27
Loading valuation history…

Fundamentals

Key fundamentals

$1.1B

Market cap

64.4%

Revenue growth (YoY)

32.5%

Gross margin

$151.6K

Free cash flow (USD)

-$830.3M

Net debt

Net cash position

0.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$412.3KFY 2017$3.2MFY 2018$12.1MFY 2019$23.8MFY 2020$46.7MFY 2021$64.6MFY 2022$86.7MFY 2023$87.2MFY 2024$117.6MFY 2025$193.4M
$412.3K$193.4M

Free cash flow by year

2016 → 2025

FY 2016$-6.0MFY 2017$-38.4MFY 2018$-91.4MFY 2019$-169.0MFY 2020$-180.3MFY 2021$-165.9MFY 2022$-94.0MFY 2023$-46.3MFY 2024$5.7MFY 2025$151.6K
-$6M$151.6K

Gross margin by year

2021 → 2025

FY 2021-27.3%FY 202217.8%FY 202313.7%FY 202421.4%FY 202532.5%
-27.3%32.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 11, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 22, 2026Filing
  • 8-K eventEarnings ReleaseMay 11, 2026Filing
  • Quarterly report10-Q FiledMay 11, 2026Filing

Questions

Frequently asked questions

What is Cronos Group Inc.'s market cap?

Cronos Group Inc. (CRON) has a market capitalization of $1.1B.

What is CRON's P/E ratio?

A meaningful P/E ratio is not available for CRON — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CRON's price-to-book (P/B) ratio?

CRON trades at 0.97 times book value per share.

Are insiders buying CRON stock?

SEC Form 4 filings show no open-market insider buys at Cronos Group Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

ALVO

Alvotech

$1.1B

COLL

Collegium Pharmaceutical, Inc.

$1.1B

EVO

Evotec SE

$1.1B

PCRX

Pacira BioSciences, Inc.

$925.6M

PAHC

Phibro Animal Health Corporation

$1.3B

AMPH

Amphastar Pharmaceuticals, Inc.

$826.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.